Full sequencing of BRCA1/2 using NGS is performed in women with breast cancer diagnosed below the age of 45 regardless of family history, in all women with triple negative breast cancer, in all women with a family history of breast and/or ovarian cancer, all men with breast cancer and all women with ovarian cancer [2,48]. This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.